Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Se Hoon Lee

Showing results (171-180 of 513) with videos related to

Pageof 52
Sort By:
Analytical Chemistry|November 26, 2013
A highly facile and specific assay for cancer-causing isocitrate dehydrogenase mutant using 13C4-labeled α-ketoglutarate and heteronuclear NMRHe Wen, Taeho Yun, Wen Jun Xu, et al.
Journal of Cancer Research and Clinical Oncology|November 21, 2014
Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancerSung Hoon Sim, Yu Jung Kim, Se Hyun Kim, et al.
Plos One|July 23, 2015
Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination ChemotherapyMiso Kim, Ja Hyeon Ku, Cheol Kwak, et al.
Annals of Nuclear Medicine|July 3, 2013
Prognostic implication of extrarenal metabolic tumor burden in advanced renal cell carcinoma treated with targeted therapy after nephrectomyHai-Jeon Yoon, Jin Chul Paeng, Cheol Kwak, et al.
Clinical Lung Cancer|December 21, 2013
Clinical significance of downstaging in patients with limited-disease small-cell lung cancerSe-Il Go, Bhumsuk Keam, Tae Min Kim, et al.
Japanese Journal of Clinical Oncology|April 16, 2008
Aggressiveness of cancer-care near the end-of-life in KoreaBhumsuk Keam, Do-Youn Oh, Se-Hoon Lee, et al.
In Vivo (Athens, Greece)|May 2, 2020
Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With <i>MET</i> Exon 14 SkippingJoon Young Hur, Bo Mi Ku, Joon Ho Shim, et al.
Lung Cancer (Amsterdam, Netherlands)|April 3, 2012
Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patientsHeae Surng Park, June Koo Lee, Dong-Wan Kim, et al.
Plos One|January 29, 2016
On the Utility of Short Echo Time (TE) Single Voxel 1H-MRS in Non-Invasive Detection of 2-Hydroxyglutarate (2HG); Challenges and Potential Improvement Illustrated with Animal Models Using MRUI and LCModelHwon Heo, Sungjin Kim, Hyeong Hun Lee, et al.
Head & Neck|November 1, 2007
Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancerYo-Han Cho, Se Hoon Lee, Dong-Wan Kim, et al.
Pageof 52

Showing results (171-180 of 513) with videos related to

Sort By:
Pageof 52
Analytical Chemistry|November 26, 2013
A highly facile and specific assay for cancer-causing isocitrate dehydrogenase mutant using 13C4-labeled α-ketoglutarate and heteronuclear NMRHe Wen, Taeho Yun, Wen Jun Xu, et al.
Journal of Cancer Research and Clinical Oncology|November 21, 2014
Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancerSung Hoon Sim, Yu Jung Kim, Se Hyun Kim, et al.
Plos One|July 23, 2015
Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination ChemotherapyMiso Kim, Ja Hyeon Ku, Cheol Kwak, et al.
Annals of Nuclear Medicine|July 3, 2013
Prognostic implication of extrarenal metabolic tumor burden in advanced renal cell carcinoma treated with targeted therapy after nephrectomyHai-Jeon Yoon, Jin Chul Paeng, Cheol Kwak, et al.
Clinical Lung Cancer|December 21, 2013
Clinical significance of downstaging in patients with limited-disease small-cell lung cancerSe-Il Go, Bhumsuk Keam, Tae Min Kim, et al.
Japanese Journal of Clinical Oncology|April 16, 2008
Aggressiveness of cancer-care near the end-of-life in KoreaBhumsuk Keam, Do-Youn Oh, Se-Hoon Lee, et al.
In Vivo (Athens, Greece)|May 2, 2020
Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With <i>MET</i> Exon 14 SkippingJoon Young Hur, Bo Mi Ku, Joon Ho Shim, et al.
Lung Cancer (Amsterdam, Netherlands)|April 3, 2012
Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patientsHeae Surng Park, June Koo Lee, Dong-Wan Kim, et al.
Plos One|January 29, 2016
On the Utility of Short Echo Time (TE) Single Voxel 1H-MRS in Non-Invasive Detection of 2-Hydroxyglutarate (2HG); Challenges and Potential Improvement Illustrated with Animal Models Using MRUI and LCModelHwon Heo, Sungjin Kim, Hyeong Hun Lee, et al.
Head & Neck|November 1, 2007
Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancerYo-Han Cho, Se Hoon Lee, Dong-Wan Kim, et al.
Pageof 52